209 related articles for article (PubMed ID: 18057712)
21. Annexin-I expression modulates drug resistance in tumor cells.
Wang Y; Serfass L; Roy MO; Wong J; Bonneau AM; Georges E
Biochem Biophys Res Commun; 2004 Feb; 314(2):565-70. PubMed ID: 14733945
[TBL] [Abstract][Full Text] [Related]
22. [Effect of different heating methods combined with neferine on the expressions of γH2AX and mdr-1/P-gp in MCF-7/Adr breast cancer cells].
Huang C; Cao P; Xie Z; Zhu H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 36(4):317-22. PubMed ID: 21566283
[TBL] [Abstract][Full Text] [Related]
23. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
Kim S; Kang J; Qiao J; Thomas RP; Evers BM; Chung DH
J Pediatr Surg; 2004 Apr; 39(4):516-21. PubMed ID: 15065019
[TBL] [Abstract][Full Text] [Related]
24. Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein.
Chen YN; Mickley LA; Schwartz AM; Acton EM; Hwang JL; Fojo AT
J Biol Chem; 1990 Jun; 265(17):10073-80. PubMed ID: 1972154
[TBL] [Abstract][Full Text] [Related]
25. [Study on apoptosis of oral squamous carcinoma cell line KB and KBv200 induced by survivin RNAi].
Yan L; Chen WQ; Liang YJ; Dai CL; Wang XH; Shi Z; Chen LM; Fu LW
Ai Zheng; 2006 Aug; 25(8):933-40. PubMed ID: 16965671
[TBL] [Abstract][Full Text] [Related]
26. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
Chao CC
FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
[TBL] [Abstract][Full Text] [Related]
27. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
Zhang MC; Hu CP; Chen Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
[TBL] [Abstract][Full Text] [Related]
28. Suppression of BCRP expression and restoration of sensitivity to chemotherapy in multidrug-resistant HCC cell line HEPG2/ADM by RNA interference.
Li H; Zhou S; Li T; Liu Z; Wu J; Zeng G; Liu C; Gong J
Hepatogastroenterology; 2012 Oct; 59(119):2238-42. PubMed ID: 23435138
[TBL] [Abstract][Full Text] [Related]
29. Lack of modulation of MDR1 gene expression by dominant inhibition of cAMP-dependent protein kinase in doxorubicin-resistant MCF-7 breast cancer cells.
Parissenti AM; Gannon BR; Villeneuve DJ; Kirwan-rhude AF; Chadderton A; Glück S
Int J Cancer; 1999 Sep; 82(6):893-900. PubMed ID: 10446459
[TBL] [Abstract][Full Text] [Related]
30. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target.
Scambia G; Ranelletti FO; Panici PB; De Vincenzo R; Bonanno G; Ferrandina G; Piantelli M; Bussa S; Rumi C; Cianfriglia M
Cancer Chemother Pharmacol; 1994; 34(6):459-64. PubMed ID: 7923555
[TBL] [Abstract][Full Text] [Related]
31. Ascorbate promotes the cellular accumulation of doxorubicin and reverses the multidrug resistance in breast cancer cells by inducing ROS-dependent ATP depletion.
Liu Y; Zhang L; Ma Z; Tian L; Liu Y; Liu Y; Chen Q; Li Y; Ma E
Free Radic Res; 2019 Jul; 53(7):758-767. PubMed ID: 31170853
[TBL] [Abstract][Full Text] [Related]
32. Reversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 Isomers, tetrataisohydroquinolin derivatives.
Yan F; Jiang Y; Li YM; Zhen X; Cen J; Fang WR
Biol Pharm Bull; 2008 Jun; 31(6):1258-64. PubMed ID: 18520065
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of survivin expression and enhanced chemosensitivity of MCF-7 cells to adriamycin by PDMAE/survivin shRNA complex nanoparticles.
Yang Y; Gao Y; Chen L; Huang Y; Li Y
Int J Pharm; 2011 Feb; 405(1-2):188-95. PubMed ID: 21130850
[TBL] [Abstract][Full Text] [Related]
34. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
35. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
[TBL] [Abstract][Full Text] [Related]
36. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
37. P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs.
Shabbits JA; Mayer LD
Mol Cancer Ther; 2002 Jan; 1(3):205-13. PubMed ID: 12467215
[TBL] [Abstract][Full Text] [Related]
38. [Effect of survivin targeting on cell proliferation and apoptosis in pancreatic cancer cells].
Dai DJ; Lu CD; Lai RY; Guo JM; Meng H
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1894-8. PubMed ID: 15631802
[TBL] [Abstract][Full Text] [Related]
39. Reversion of P-glycoprotein-mediated multidrug resistance in human leukemic cell line by carnosic acid.
Yu XN; Chen XL; Li H; Li XX; Li HQ; Jin WR
Chin J Physiol; 2008 Dec; 51(6):348-56. PubMed ID: 19280878
[TBL] [Abstract][Full Text] [Related]
40. Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation.
Nielsen D; Maare C; Eriksen J; Litman T; Skovsgaard T
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1050-7. PubMed ID: 11704330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]